Clinical trials
Recruiting Phase 2/3 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 2 |
| Banner Health | 1 |
| Nelly Pitteloud | 1 |
| Wanbangde Pharmaceutical Group Co., LTD | 1 |
| prof. dr. Koen Van Laere | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 6 |
| Dementia | 4 |
| Cognitive Dysfunction | 1 |
| Down Syndrome | 1 |
| Lewy Body Disease | 1 |
| Movement Disorders | 1 |
| Olfaction Disorders | 1 |
| Parkinson Disease | 1 |
| Parkinsonian Disorders | 1 |
| Primary Dysautonomias | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.